Should healthcare teams prioritise continuous third-party monitoring over annual questionnaires?

Why healthcare supplier risk can’t be treated as an annual snapshot

Annual questionnaires still have value for procurement because they document a supplier’s stated controls, contracts, and attestation at a point in time. The problem is that healthcare exposure changes faster than an annual review cycle can capture. Access paths, integrations, credentials, and hosted services can change between reviews, which means the organisation may be relying on outdated assurances while patient-impacting systems are already exposed.

Continuous third-party monitoring is better aligned to the pace of modern supplier risk because it can surface changes in access, posture, and external exposure as they occur. In practice, that matters most for suppliers connected to clinical workflows, claims, scheduling, billing, support portals, and any environment that touches protected health information or privileged integration paths.

A useful way to think about it is that questionnaires answer, “What did the supplier say last quarter?” while monitoring answers, “What is true now?” Both have a place, but they solve different problems. Healthcare teams should treat the questionnaire as a baseline governance artifact and continuous monitoring as the operational control that catches drift, stale access, and new weaknesses before they become operational incidents.

What continuous monitoring catches that questionnaires miss

Questionnaires rarely reveal whether a supplier’s reality has changed after the form was submitted. Continuous monitoring is more effective at spotting signals such as newly exposed internet-facing services, expired or misconfigured certificates, leaked secrets, risky access changes, and evidence that a supplier’s security posture has deteriorated since the last review. That is especially relevant where supplier systems authenticate into healthcare environments or hold data that can cascade into downstream clinical disruption.

For healthcare teams, the most important difference is not just visibility, it is timeliness. A supplier can remain “compliant” on paper while a token, API key, or remote-access path has already been abused, overextended, or left active far longer than intended. Third-Party, B2B and Contractor Access Guide is useful here because it frames supplier access as a lifecycle issue, not a one-time approval.

Monitoring also helps separate low-risk vendors from high-risk dependencies. A supplier with no production integration, no sensitive data, and no privileged access may warrant periodic questionnaires and lighter checks. A supplier with clinical or operational access, privileged support, or authentication into core systems should be monitored continuously because the consequence of drift is materially higher.

How healthcare teams should decide the balance

The right model is usually not “monitor everything equally.” It is risk-based. Annual questionnaires can still support onboarding, contract renewal, and audit evidence, but they should not be the only control for suppliers that can affect patient care, system availability, or protected data. The more a supplier can change access, code, integrations, or credentials without your team seeing it, the more continuous monitoring should dominate the control mix.

Teams should prioritise suppliers with any of the following characteristics: privileged remote support, API or SSO integration, hosted clinical workflows, outsourced operations, access to protected health information, or dependencies that could interrupt care if they fail. Those are the relationships where a stale questionnaire is least trustworthy and where current posture matters most. IAM and IGA Basics is a strong companion reference because supplier monitoring only becomes effective when access ownership, review, and revocation are part of the operating model.

Healthcare teams should also decide who owns the signal. Procurement can track assurance and contract terms, but security usually needs to own the monitoring thresholds, escalation rules, and response workflow. If monitoring alerts cannot trigger access review, vendor contact, or containment, they are just reports. The control only works when it is tied to an action path.

Risk and Threat Considerations

Supplier risk in healthcare is not limited to compliance drift. A third party can become the shortest path to exposed patient information, service disruption, or privileged access abuse if stale credentials, overbroad permissions, or unmanaged integrations are left in place. Annual questionnaires often miss that gap because they describe intended controls rather than current exposure.

Failure mechanism: A supplier can remain approved while its real-world access footprint changes through token theft, stale accounts, exposed keys, or new integrations that never re-enter the review cycle. That creates a blind spot between formal attestation and actual access conditions.

Impact: The result can be data exposure, unauthorised access to clinical or administrative systems, delayed containment, and in the worst case, disruption to patient-facing operations. Continuous monitoring reduces that window by surfacing change fast enough to act before the supplier relationship turns into an incident path.

Practitioner Guidance

What to prioritise: Put continuous monitoring in place first for suppliers that have privileged access, SSO or API connections, hosted workflows, or access to protected health information. Those relationships carry the highest blast radius, so they deserve the fastest feedback loop.

What to verify: Make sure monitoring is actually tied to ownership and response. If an alert cannot lead to access review, token rotation, supplier escalation, or temporary suspension, the monitoring program is informational only and will not materially reduce exposure.

Decision rule: Use annual questionnaires for governance, onboarding, and contractual evidence; use continuous monitoring for operational risk detection. If the supplier can change its access posture between annual reviews, treat monitoring as the primary control.

Practitioner takeaway: Healthcare teams should not choose between questionnaires and monitoring as if they were substitutes. The questionnaire establishes intent, but continuous monitoring is what tells you whether the supplier remains safe to trust today.

Related resources from NHI Mgmt Group

• When should organisations prioritise continuous monitoring over relying on questionnaire responses alone for third-party risk decisions?
• How should security teams replace annual vendor questionnaires with a continuous third-party risk management program?
• When should organisations prioritise continuous vendor monitoring over annual assessments?
• What breaks when organisations rely on vendor questionnaires instead of continuous third-party identity monitoring?